피플바이오

304840KOSDAQ의료용품 및 기타 의약 관련제품 제조업

58.2 / 100

Reference Date: 2026-07-24

Financial Score20.0 / 40

News Sentiment19.2 / 25

Momentum9.0 / 20

Disclosure10.0 / 15

AI Analysis: PBR is significantly undervalued vs. peers but Revenue is on a declining trend. Slightly down 2.2% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

PeopleBio is a biotech company specializing in the development of biomarker-based diagnostic technologies for early detection of Alzheimer's disease. The company's SI-MDS technology enables the detection of oligomeric beta-amyloid through blood tests, offering a cost-effective and efficient alternative to existing methods like PET or lumbar puncture. With rising demand for dementia diagnostics due to aging populations, the market is expected to grow significantly.

Number of Employees

43people

Average Salary

60.3M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 15.184.0Point

PBR

0.67Industry Average 1.095.5Point

Lower than industry avg (good)

ROE

-93.48Industry Average -4.893.5Point

19.1x industry avg (excellent)

Debt Ratio

6.75Industry Average 6.864.0Point

In line with industry avg

Trend 2023~20253.0 / 10 points

Revenue Growth Rate

0.0 / 3

Avg ▼19.9% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲25.9% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -106.2% (improving, 3yr)

Detailed News Sentiment

8 totalPositive 7Neutral 1Negative 0Average Sentiment Score 76.9

Positive
피플바이오, ‘타임엑스에이아이(TimeX AI)’로 사명 변경
피플바이오의 사명 변경과 AI 인프라 사업 확장 발표로 인해 긍정적인 시장 반응 예상.
Neutral
피플바이오, 타임엑스에이아이로 상호 변경
회사의 비전 변경으로 인한 사명 변경 공시지만, 피플바이오의 주식에 직접적인 영향은 제한적임.
Positive
피플바이오, 2분기 매출 128% 증가...영업손실 절반 이상 축소
피 PEOPLE바이오의 2분기 매출이 전년 동기 대비 128% 증가하고 영업손실이 크게 줄어들어 수익성이 크게 개선되었다.

Detailed Momentum

52-week position1.0Point

Near 52w low (6%, downtrend)

Current 792Won52-week high 2,61052-week low 671

1-month return2.0Point

1m -2.22% (slight drop)

Volume trend6.0Point

Volume surge

Detailed Disclosure

9 totalPositive 0Neutral 9Negative 0

Neutral상호변경안내2026-07-20
Neutral임시주주총회결과2026-07-20
Neutral연결재무제표기준영업(잠정)실적(공정공시)2026-07-16
Neutral[기재정정]의결권대리행사권유참고서류2026-07-07
Neutral[기재정정]주주총회소집결의 (임시주주총회)2026-07-03